

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 9.75329057 |
| 2 | viral transcription (GO:0019083) | 7.48485298 |
| 3 | translational termination (GO:0006415) | 7.14611854 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.64879315 |
| 5 | platelet dense granule organization (GO:0060155) | 6.34045215 |
| 6 | ribosomal small subunit biogenesis (GO:0042274) | 6.22460359 |
| 7 | translational elongation (GO:0006414) | 6.15013467 |
| 8 | DNA deamination (GO:0045006) | 6.09262346 |
| 9 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.07124097 |
| 10 | definitive hemopoiesis (GO:0060216) | 5.94041340 |
| 11 | cotranslational protein targeting to membrane (GO:0006613) | 5.93921410 |
| 12 | protein targeting to ER (GO:0045047) | 5.91244607 |
| 13 | maturation of SSU-rRNA (GO:0030490) | 5.71825820 |
| 14 | protein localization to endoplasmic reticulum (GO:0070972) | 5.67348499 |
| 15 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.63261480 |
| 16 | viral life cycle (GO:0019058) | 5.55322718 |
| 17 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.50395180 |
| 18 | antigen processing and presentation via MHC class Ib (GO:0002475) | 5.30561979 |
| 19 | cellular protein complex disassembly (GO:0043624) | 5.29721801 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.23272166 |
| 21 | negative regulation of cell killing (GO:0031342) | 5.23272166 |
| 22 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.15047267 |
| 23 | translational initiation (GO:0006413) | 4.95532700 |
| 24 | mature B cell differentiation involved in immune response (GO:0002313) | 4.82683043 |
| 25 | * response to interferon-beta (GO:0035456) | 4.74159579 |
| 26 | protein complex disassembly (GO:0043241) | 4.73465551 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.64013977 |
| 28 | megakaryocyte development (GO:0035855) | 4.47131791 |
| 29 | macromolecular complex disassembly (GO:0032984) | 4.40028925 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.38272977 |
| 31 | cellular response to interleukin-15 (GO:0071350) | 4.21311118 |
| 32 | endosome to melanosome transport (GO:0035646) | 4.20741346 |
| 33 | endosome to pigment granule transport (GO:0043485) | 4.20741346 |
| 34 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 4.09242410 |
| 35 | response to interleukin-15 (GO:0070672) | 4.03459217 |
| 36 | negative T cell selection (GO:0043383) | 4.02157107 |
| 37 | cytidine catabolic process (GO:0006216) | 4.00669904 |
| 38 | cytidine deamination (GO:0009972) | 4.00669904 |
| 39 | cytidine metabolic process (GO:0046087) | 4.00669904 |
| 40 | secretory granule organization (GO:0033363) | 3.97040776 |
| 41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.95618588 |
| 42 | mRNA catabolic process (GO:0006402) | 3.95164673 |
| 43 | protein targeting to membrane (GO:0006612) | 3.88082280 |
| 44 | * response to interferon-alpha (GO:0035455) | 3.85731790 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.84856958 |
| 46 | negative thymic T cell selection (GO:0045060) | 3.83142181 |
| 47 | leukocyte aggregation (GO:0070486) | 3.75288627 |
| 48 | defense response to protozoan (GO:0042832) | 3.69257226 |
| 49 | RNA catabolic process (GO:0006401) | 3.67040711 |
| 50 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.66844908 |
| 51 | response to protozoan (GO:0001562) | 3.65520921 |
| 52 | lymph node development (GO:0048535) | 3.60667698 |
| 53 | mature B cell differentiation (GO:0002335) | 3.60063632 |
| 54 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.59802486 |
| 55 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.59802486 |
| 56 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.59733818 |
| 57 | cellular response to interferon-beta (GO:0035458) | 3.58928883 |
| 58 | positive regulation of B cell differentiation (GO:0045579) | 3.57703911 |
| 59 | ribosomal large subunit biogenesis (GO:0042273) | 3.57158680 |
| 60 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.47536491 |
| 61 | proteasome assembly (GO:0043248) | 3.46370285 |
| 62 | T cell migration (GO:0072678) | 3.45376216 |
| 63 | detection of bacterium (GO:0016045) | 3.44386431 |
| 64 | * regulation of viral genome replication (GO:0045069) | 3.43326016 |
| 65 | lymphoid progenitor cell differentiation (GO:0002320) | 3.42794083 |
| 66 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.41499283 |
| 67 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.41181471 |
| 68 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.40248781 |
| 69 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.39273279 |
| 70 | positive thymic T cell selection (GO:0045059) | 3.35592137 |
| 71 | daunorubicin metabolic process (GO:0044597) | 3.34708560 |
| 72 | polyketide metabolic process (GO:0030638) | 3.34708560 |
| 73 | doxorubicin metabolic process (GO:0044598) | 3.34708560 |
| 74 | translation (GO:0006412) | 3.32829232 |
| 75 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.32632346 |
| 76 | Peyers patch development (GO:0048541) | 3.32632346 |
| 77 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.30335610 |
| 78 | purine-containing compound salvage (GO:0043101) | 3.28666068 |
| 79 | detection of other organism (GO:0098543) | 3.27872993 |
| 80 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.26663690 |
| 81 | positive regulation of respiratory burst (GO:0060267) | 3.23715587 |
| 82 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.23354825 |
| 83 | regulation of T cell tolerance induction (GO:0002664) | 3.23322364 |
| 84 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.18767089 |
| 85 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.17817409 |
| 86 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.16719807 |
| 87 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.16719807 |
| 88 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.15538576 |
| 89 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.15538576 |
| 90 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.15158993 |
| 91 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.15158993 |
| 92 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.15158993 |
| 93 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.11499046 |
| 94 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.10304978 |
| 95 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.10273808 |
| 96 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.08387417 |
| 97 | negative regulation of phagocytosis (GO:0050765) | 3.06725493 |
| 98 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.04592610 |
| 99 | negative regulation of ligase activity (GO:0051352) | 3.04592610 |
| 100 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.03648370 |
| 101 | thymic T cell selection (GO:0045061) | 3.02169342 |
| 102 | pseudouridine synthesis (GO:0001522) | 3.01318144 |
| 103 | interferon-gamma production (GO:0032609) | 3.01111228 |
| 104 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.01102477 |
| 105 | * defense response to virus (GO:0051607) | 2.99752508 |
| 106 | positive T cell selection (GO:0043368) | 2.99110940 |
| 107 | regulation of B cell differentiation (GO:0045577) | 2.98708700 |
| 108 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.98474789 |
| 109 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.98474789 |
| 110 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.97970119 |
| 111 | regulation of respiratory burst (GO:0060263) | 2.97885208 |
| 112 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.97481875 |
| 113 | regulation of erythrocyte differentiation (GO:0045646) | 2.96650519 |
| 114 | positive regulation of interferon-alpha production (GO:0032727) | 2.96551525 |
| 115 | respiratory chain complex IV assembly (GO:0008535) | 2.93599593 |
| 116 | positive regulation by symbiont of host defense response (GO:0052509) | 2.92751884 |
| 117 | modulation by symbiont of host defense response (GO:0052031) | 2.92751884 |
| 118 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.92751884 |
| 119 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.92751884 |
| 120 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.92751884 |
| 121 | modulation by symbiont of host immune response (GO:0052553) | 2.92751884 |
| 122 | positive regulation of T cell mediated immunity (GO:0002711) | 2.92573099 |
| 123 | negative regulation of T cell mediated immunity (GO:0002710) | 2.91565332 |
| 124 | * negative regulation of viral process (GO:0048525) | 2.91506474 |
| 125 | regulation of regulatory T cell differentiation (GO:0045589) | 2.91353660 |
| 126 | cellular response to interferon-alpha (GO:0035457) | 2.91151094 |
| 127 | negative regulation of bone mineralization (GO:0030502) | 2.90722689 |
| 128 | negative regulation of innate immune response (GO:0045824) | 2.90162059 |
| 129 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.90036132 |
| 130 | regulation of natural killer cell differentiation (GO:0032823) | 2.89157554 |
| 131 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.89046225 |
| 132 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.86940960 |
| 133 | myeloid dendritic cell activation (GO:0001773) | 2.86875031 |
| 134 | respiratory burst (GO:0045730) | 2.85906163 |
| 135 | positive regulation of cell killing (GO:0031343) | 2.85518946 |
| 136 | regulation of cell killing (GO:0031341) | 2.84449959 |
| 137 | fucose catabolic process (GO:0019317) | 2.83992503 |
| 138 | L-fucose metabolic process (GO:0042354) | 2.83992503 |
| 139 | L-fucose catabolic process (GO:0042355) | 2.83992503 |
| 140 | T cell selection (GO:0045058) | 2.83735492 |
| 141 | T cell homeostasis (GO:0043029) | 2.83490031 |
| 142 | * response to type I interferon (GO:0034340) | 2.82624585 |
| 143 | * cellular response to type I interferon (GO:0071357) | 2.81358754 |
| 144 | * type I interferon signaling pathway (GO:0060337) | 2.81358754 |
| 145 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.81310617 |
| 146 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.80813070 |
| 147 | neutrophil activation involved in immune response (GO:0002283) | 2.80710919 |
| 148 | heparin biosynthetic process (GO:0030210) | 2.79323494 |
| 149 | heparin metabolic process (GO:0030202) | 2.79323494 |
| 150 | regulation of interferon-alpha production (GO:0032647) | 2.79057774 |
| 151 | positive regulation of defense response to virus by host (GO:0002230) | 2.78511150 |
| 152 | regulation of T cell mediated immunity (GO:0002709) | 2.77997567 |
| 153 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.77526729 |
| 154 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.77285234 |
| 155 | formation of translation preinitiation complex (GO:0001731) | 2.76439157 |
| 156 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.75546539 |
| 157 | * negative regulation of viral genome replication (GO:0045071) | 2.74856096 |
| 158 | tRNA methylation (GO:0030488) | 2.70068629 |
| 159 | B cell mediated immunity (GO:0019724) | 2.69521268 |
| 160 | positive regulation of granulocyte differentiation (GO:0030854) | 2.68382825 |
| 161 | myeloid dendritic cell differentiation (GO:0043011) | 2.67988847 |
| 162 | * negative regulation of viral entry into host cell (GO:0046597) | 2.67600142 |
| 163 | granulocyte differentiation (GO:0030851) | 2.67084659 |
| 164 | rRNA processing (GO:0006364) | 2.66333179 |
| 165 | cellular component biogenesis (GO:0044085) | 2.65618955 |
| 166 | immunoglobulin mediated immune response (GO:0016064) | 2.65249971 |
| 167 | IMP metabolic process (GO:0046040) | 2.62216420 |
| 168 | thrombin receptor signaling pathway (GO:0070493) | 2.61913020 |
| 169 | regulation of gamma-delta T cell activation (GO:0046643) | 2.61392325 |
| 170 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.61210417 |
| 171 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.60174377 |
| 172 | embryonic hemopoiesis (GO:0035162) | 2.59672995 |
| 173 | T-helper 1 type immune response (GO:0042088) | 2.59086614 |
| 174 | phospholipid scrambling (GO:0017121) | 2.58941142 |
| 175 | mast cell activation (GO:0045576) | 2.57829755 |
| 176 | B cell activation involved in immune response (GO:0002312) | 2.57818644 |
| 177 | rRNA metabolic process (GO:0016072) | 2.56536561 |
| 178 | establishment of protein localization to membrane (GO:0090150) | 2.55160955 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.58550276 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.00290469 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.58637147 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.39926615 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.38944725 |
| 6 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.24895888 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.21387491 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.99363543 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.98567593 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.94244447 |
| 11 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.93573088 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.93251031 |
| 13 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.73652389 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.73478104 |
| 15 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.66082568 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.57321703 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.50882220 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.50125816 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.40813108 |
| 20 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.30097524 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25620389 |
| 22 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.23420635 |
| 23 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.22814178 |
| 24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.18452623 |
| 25 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.15785453 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.13470324 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.12978276 |
| 28 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.11240666 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.07816349 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 2.05422891 |
| 31 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.02015427 |
| 32 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.99676646 |
| 33 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.99058700 |
| 34 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97289837 |
| 35 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.90787865 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.87675497 |
| 37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.85899466 |
| 38 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.84883311 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84366601 |
| 40 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.81469794 |
| 41 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.80380671 |
| 42 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.76122560 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.74362724 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.73531534 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.69431582 |
| 46 | GATA3_26560356_Chip-Seq_TH2_Human | 1.67608158 |
| 47 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.66556244 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.66532549 |
| 49 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.64446605 |
| 50 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.62802783 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.61894799 |
| 52 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.57877077 |
| 53 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54037531 |
| 54 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.52354462 |
| 55 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.50255844 |
| 56 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.48710528 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.48200352 |
| 58 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.47732660 |
| 59 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.46802258 |
| 60 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.46802258 |
| 61 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.46802258 |
| 62 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.46072718 |
| 63 | * MAF_26560356_Chip-Seq_TH1_Human | 1.44067674 |
| 64 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.43737614 |
| 65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.43713592 |
| 66 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.40272219 |
| 67 | MYB_26560356_Chip-Seq_TH2_Human | 1.39432309 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38390431 |
| 69 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.37627424 |
| 70 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.36359672 |
| 71 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.34777161 |
| 72 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.31934994 |
| 73 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.31515973 |
| 74 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28744780 |
| 75 | * MYB_26560356_Chip-Seq_TH1_Human | 1.27875577 |
| 76 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.27584125 |
| 77 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.26206829 |
| 78 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26032491 |
| 79 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.25039861 |
| 80 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.24492602 |
| 81 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.24437304 |
| 82 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.23532882 |
| 83 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23492162 |
| 84 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.23401883 |
| 85 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.20043209 |
| 86 | SPI1_23127762_ChIP-Seq_K562_Human | 1.19933683 |
| 87 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19602149 |
| 88 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19213521 |
| 89 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.18127320 |
| 90 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.16367593 |
| 91 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16323840 |
| 92 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.15541299 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14055475 |
| 94 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.13569790 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12915642 |
| 96 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07824925 |
| 97 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.07367146 |
| 98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07334728 |
| 99 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.06360823 |
| 100 | * MAF_26560356_Chip-Seq_TH2_Human | 1.05185049 |
| 101 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.05072522 |
| 102 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04863508 |
| 103 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.04342875 |
| 104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00256264 |
| 105 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00087714 |
| 106 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.00029430 |
| 107 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.99974481 |
| 108 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99743823 |
| 109 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.99106176 |
| 110 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98344419 |
| 111 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98162952 |
| 112 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.96107717 |
| 113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95820661 |
| 114 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94537363 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93332107 |
| 116 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.93022583 |
| 117 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91814875 |
| 118 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.91768858 |
| 119 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.91720436 |
| 120 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90302331 |
| 121 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.88427488 |
| 122 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.88159527 |
| 123 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.87325527 |
| 124 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.86666805 |
| 125 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.86438091 |
| 126 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85231098 |
| 127 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.84674652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 3.39749580 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.38034043 |
| 3 | MP0005174_abnormal_tail_pigmentation | 3.31519145 |
| 4 | MP0004808_abnormal_hematopoietic_stem | 3.29558569 |
| 5 | MP0001545_abnormal_hematopoietic_system | 3.26312570 |
| 6 | MP0005397_hematopoietic_system_phenotyp | 3.26312570 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.25502024 |
| 8 | MP0000685_abnormal_immune_system | 3.18066227 |
| 9 | MP0009785_altered_susceptibility_to | 3.00794448 |
| 10 | MP0005671_abnormal_response_to | 2.71543932 |
| 11 | MP0005464_abnormal_platelet_physiology | 2.59811013 |
| 12 | MP0005075_abnormal_melanosome_morpholog | 2.58655728 |
| 13 | MP0000465_gastrointestinal_hemorrhage | 2.52011198 |
| 14 | MP0002254_reproductive_system_inflammat | 2.46630076 |
| 15 | MP0002877_abnormal_melanocyte_morpholog | 2.46403945 |
| 16 | MP0009278_abnormal_bone_marrow | 2.33185391 |
| 17 | MP0005025_abnormal_response_to | 2.29274994 |
| 18 | MP0000490_abnormal_crypts_of | 2.28766355 |
| 19 | MP0003866_abnormal_defecation | 2.19442788 |
| 20 | MP0002095_abnormal_skin_pigmentation | 2.16842902 |
| 21 | MP0003724_increased_susceptibility_to | 2.13797701 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.10512992 |
| 23 | MP0002398_abnormal_bone_marrow | 2.08873151 |
| 24 | MP0003806_abnormal_nucleotide_metabolis | 2.00489789 |
| 25 | MP0003436_decreased_susceptibility_to | 2.00007210 |
| 26 | MP0001800_abnormal_humoral_immune | 1.99838376 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.99335563 |
| 28 | MP0000689_abnormal_spleen_morphology | 1.91865913 |
| 29 | MP0002277_abnormal_respiratory_mucosa | 1.90721238 |
| 30 | MP0001853_heart_inflammation | 1.90534086 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.89950458 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.89002810 |
| 33 | MP0002723_abnormal_immune_serum | 1.87675286 |
| 34 | MP0003763_abnormal_thymus_physiology | 1.87009540 |
| 35 | MP0001819_abnormal_immune_cell | 1.85949497 |
| 36 | MP0002722_abnormal_immune_system | 1.84643849 |
| 37 | MP0000716_abnormal_immune_system | 1.75268954 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.74510408 |
| 39 | MP0001873_stomach_inflammation | 1.73961229 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.67223912 |
| 41 | MP0001986_abnormal_taste_sensitivity | 1.66067236 |
| 42 | MP0002429_abnormal_blood_cell | 1.65670403 |
| 43 | MP0004147_increased_porphyrin_level | 1.60699595 |
| 44 | MP0002419_abnormal_innate_immunity | 1.59914041 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.50636670 |
| 46 | MP0003693_abnormal_embryo_hatching | 1.50515695 |
| 47 | MP0005387_immune_system_phenotype | 1.47661520 |
| 48 | MP0001790_abnormal_immune_system | 1.47661520 |
| 49 | MP0006292_abnormal_olfactory_placode | 1.45560907 |
| 50 | MP0010368_abnormal_lymphatic_system | 1.42974438 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.40306573 |
| 52 | MP0002166_altered_tumor_susceptibility | 1.37785369 |
| 53 | MP0008058_abnormal_DNA_repair | 1.35404499 |
| 54 | MP0000858_altered_metastatic_potential | 1.34514289 |
| 55 | MP0002933_joint_inflammation | 1.29840756 |
| 56 | MP0003943_abnormal_hepatobiliary_system | 1.29195685 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.24547053 |
| 58 | MP0008007_abnormal_cellular_replicative | 1.23939342 |
| 59 | MP0001845_abnormal_inflammatory_respons | 1.23082838 |
| 60 | MP0000372_irregular_coat_pigmentation | 1.21729142 |
| 61 | MP0002405_respiratory_system_inflammati | 1.20823350 |
| 62 | MP0002234_abnormal_pharynx_morphology | 1.18588794 |
| 63 | MP0003303_peritoneal_inflammation | 1.18362771 |
| 64 | MP0003136_yellow_coat_color | 1.15859920 |
| 65 | MP0008057_abnormal_DNA_replication | 1.15150576 |
| 66 | MP0008469_abnormal_protein_level | 1.13633520 |
| 67 | MP0005409_darkened_coat_color | 1.11054227 |
| 68 | MP0003011_delayed_dark_adaptation | 1.10561598 |
| 69 | MP0004957_abnormal_blastocyst_morpholog | 1.10369210 |
| 70 | MP0004381_abnormal_hair_follicle | 1.09639282 |
| 71 | MP0002132_abnormal_respiratory_system | 1.07320558 |
| 72 | MP0003448_altered_tumor_morphology | 1.04840715 |
| 73 | MP0002006_tumorigenesis | 1.03095578 |
| 74 | MP0002019_abnormal_tumor_incidence | 1.02959179 |
| 75 | MP0003868_abnormal_feces_composition | 1.02402687 |
| 76 | MP0002163_abnormal_gland_morphology | 1.01954117 |
| 77 | MP0003077_abnormal_cell_cycle | 1.00565108 |
| 78 | MP0003828_pulmonary_edema | 1.00450015 |
| 79 | MP0010094_abnormal_chromosome_stability | 0.98404545 |
| 80 | MP0003186_abnormal_redox_activity | 0.97859885 |
| 81 | MP0008004_abnormal_stomach_pH | 0.97817722 |
| 82 | MP0000313_abnormal_cell_death | 0.96437689 |
| 83 | MP0006082_CNS_inflammation | 0.94703893 |
| 84 | MP0008995_early_reproductive_senescence | 0.92103592 |
| 85 | MP0006054_spinal_hemorrhage | 0.92093069 |
| 86 | MP0005390_skeleton_phenotype | 0.91902968 |
| 87 | MP0005310_abnormal_salivary_gland | 0.91190968 |
| 88 | MP0000681_abnormal_thyroid_gland | 0.91058888 |
| 89 | MP0001879_abnormal_lymphatic_vessel | 0.90714246 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 0.89821394 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 0.87772751 |
| 92 | MP0008872_abnormal_physiological_respon | 0.87751125 |
| 93 | MP0000477_abnormal_intestine_morphology | 0.86557959 |
| 94 | MP0003567_abnormal_fetal_cardiomyocyte | 0.83140533 |
| 95 | MP0001663_abnormal_digestive_system | 0.81597067 |
| 96 | MP0003195_calcinosis | 0.81106061 |
| 97 | MP0003191_abnormal_cellular_cholesterol | 0.80669535 |
| 98 | MP0001348_abnormal_lacrimal_gland | 0.79805625 |
| 99 | MP0005503_abnormal_tendon_morphology | 0.78919644 |
| 100 | MP0005166_decreased_susceptibility_to | 0.76514255 |
| 101 | MP0002075_abnormal_coat/hair_pigmentati | 0.74912510 |
| 102 | MP0004510_myositis | 0.74861462 |
| 103 | MP0000343_altered_response_to | 0.74760701 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.74744366 |
| 105 | MP0004947_skin_inflammation | 0.73842331 |
| 106 | MP0009764_decreased_sensitivity_to | 0.71457435 |
| 107 | MP0001851_eye_inflammation | 0.70701075 |
| 108 | MP0001533_abnormal_skeleton_physiology | 0.69947725 |
| 109 | MP0001542_abnormal_bone_strength | 0.69691369 |
| 110 | MP0002089_abnormal_postnatal_growth/wei | 0.67836882 |
| 111 | MP0002998_abnormal_bone_remodeling | 0.67772282 |
| 112 | MP0003786_premature_aging | 0.66844607 |
| 113 | MP0003300_gastrointestinal_ulcer | 0.66371626 |
| 114 | MP0000371_diluted_coat_color | 0.65654633 |
| 115 | MP0008260_abnormal_autophagy | 0.65114226 |
| 116 | MP0003638_abnormal_response/metabolism_ | 0.64947959 |
| 117 | MP0003890_abnormal_embryonic-extraembry | 0.64157401 |
| 118 | MP0002938_white_spotting | 0.63594508 |
| 119 | MP0009763_increased_sensitivity_to | 0.63586431 |
| 120 | MP0002177_abnormal_outer_ear | 0.62136543 |
| 121 | MP0003795_abnormal_bone_structure | 0.61924034 |
| 122 | MP0000678_abnormal_parathyroid_gland | 0.61887464 |
| 123 | MP0005670_abnormal_white_adipose | 0.61763708 |
| 124 | MP0001188_hyperpigmentation | 0.61676221 |
| 125 | MP0000598_abnormal_liver_morphology | 0.61540608 |
| 126 | MP0004883_abnormal_blood_vessel | 0.59871657 |
| 127 | MP0000613_abnormal_salivary_gland | 0.59719673 |
| 128 | MP0008873_increased_physiological_sensi | 0.58628766 |
| 129 | MP0006035_abnormal_mitochondrial_morpho | 0.57547462 |
| 130 | MP0001881_abnormal_mammary_gland | 0.57193830 |
| 131 | MP0005319_abnormal_enzyme/_coenzyme | 0.53271287 |
| 132 | MP0001919_abnormal_reproductive_system | 0.52036272 |
| 133 | MP0001764_abnormal_homeostasis | 0.50503219 |
| 134 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.50093105 |
| 135 | MP0005083_abnormal_biliary_tract | 0.47286112 |
| 136 | MP0005084_abnormal_gallbladder_morpholo | 0.44022436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thrombocytosis (HP:0001894) | 6.34693863 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.16557747 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 5.83781444 |
| 4 | Aplastic anemia (HP:0001915) | 5.28310827 |
| 5 | Reticulocytopenia (HP:0001896) | 5.10223142 |
| 6 | Prolonged bleeding time (HP:0003010) | 4.84246422 |
| 7 | Eczematoid dermatitis (HP:0000976) | 4.52657379 |
| 8 | Stomatitis (HP:0010280) | 4.34881052 |
| 9 | IgM deficiency (HP:0002850) | 4.13184510 |
| 10 | Petechiae (HP:0000967) | 4.11188064 |
| 11 | Increased IgM level (HP:0003496) | 4.03918384 |
| 12 | Myositis (HP:0100614) | 3.99044000 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.95082673 |
| 14 | Type 2 muscle fiber atrophy (HP:0003554) | 3.84347742 |
| 15 | Abnormality of T cell number (HP:0011839) | 3.84301263 |
| 16 | Pallor (HP:0000980) | 3.76979999 |
| 17 | Muscle fiber atrophy (HP:0100295) | 3.75655031 |
| 18 | Nonprogressive disorder (HP:0003680) | 3.68259336 |
| 19 | T lymphocytopenia (HP:0005403) | 3.67156206 |
| 20 | Encephalitis (HP:0002383) | 3.59931323 |
| 21 | Epistaxis (HP:0000421) | 3.48364362 |
| 22 | Macrocytic anemia (HP:0001972) | 3.43320654 |
| 23 | Autoimmune hemolytic anemia (HP:0001890) | 3.37154677 |
| 24 | Type I transferrin isoform profile (HP:0003642) | 3.36772409 |
| 25 | Pustule (HP:0200039) | 3.33584006 |
| 26 | Amaurosis fugax (HP:0100576) | 3.33001006 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.22935323 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.22935323 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.18987874 |
| 30 | Keratoconjunctivitis sicca (HP:0001097) | 3.16479109 |
| 31 | Abnormal platelet function (HP:0011869) | 3.15163965 |
| 32 | Impaired platelet aggregation (HP:0003540) | 3.15163965 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 3.14050375 |
| 34 | Keratoconjunctivitis (HP:0001096) | 3.12029557 |
| 35 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.09630265 |
| 36 | Abnormality of T cell physiology (HP:0011840) | 3.09246850 |
| 37 | Eosinophilia (HP:0001880) | 3.07564828 |
| 38 | Granulocytopenia (HP:0001913) | 3.06229681 |
| 39 | Mediastinal lymphadenopathy (HP:0100721) | 2.99073068 |
| 40 | Reduced antithrombin III activity (HP:0001976) | 2.97531098 |
| 41 | Anorexia (HP:0002039) | 2.94945734 |
| 42 | Myelodysplasia (HP:0002863) | 2.93415218 |
| 43 | Lymphopenia (HP:0001888) | 2.90020275 |
| 44 | Recurrent skin infections (HP:0001581) | 2.86639281 |
| 45 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.84131619 |
| 46 | Leukocytosis (HP:0001974) | 2.82131604 |
| 47 | Radial bowing (HP:0002986) | 2.80677679 |
| 48 | Chronic otitis media (HP:0000389) | 2.79117486 |
| 49 | Obstructive lung disease (HP:0006536) | 2.78533761 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.78533761 |
| 51 | Severe combined immunodeficiency (HP:0004430) | 2.77265710 |
| 52 | Abnormality of the nasal mucosa (HP:0000433) | 2.75327294 |
| 53 | Colon cancer (HP:0003003) | 2.74718001 |
| 54 | Abnormality of eosinophils (HP:0001879) | 2.70127384 |
| 55 | Purpura (HP:0000979) | 2.69974485 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.66813269 |
| 57 | Respiratory difficulties (HP:0002880) | 2.64106133 |
| 58 | Hypochromic anemia (HP:0001931) | 2.63340744 |
| 59 | Abnormality of B cell number (HP:0010975) | 2.59113444 |
| 60 | Mitochondrial inheritance (HP:0001427) | 2.58158114 |
| 61 | Hypergammaglobulinemia (HP:0010702) | 2.57793359 |
| 62 | Beaking of vertebral bodies (HP:0004568) | 2.57524745 |
| 63 | Gingival bleeding (HP:0000225) | 2.57325949 |
| 64 | Pulmonary infiltrates (HP:0002113) | 2.55461769 |
| 65 | Stomach cancer (HP:0012126) | 2.54395945 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.53095148 |
| 67 | Acute necrotizing encephalopathy (HP:0006965) | 2.52147695 |
| 68 | Urticaria (HP:0001025) | 2.52026436 |
| 69 | Asplenia (HP:0001746) | 2.51566209 |
| 70 | Albinism (HP:0001022) | 2.50482583 |
| 71 | Weak cry (HP:0001612) | 2.47961682 |
| 72 | Panhypogammaglobulinemia (HP:0003139) | 2.47943764 |
| 73 | 11 pairs of ribs (HP:0000878) | 2.47675682 |
| 74 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.47540603 |
| 75 | Cellulitis (HP:0100658) | 2.46872833 |
| 76 | Hemoptysis (HP:0002105) | 2.46240805 |
| 77 | Recurrent abscess formation (HP:0002722) | 2.44619031 |
| 78 | Orchitis (HP:0100796) | 2.44178047 |
| 79 | Increased IgE level (HP:0003212) | 2.43464075 |
| 80 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.43222732 |
| 81 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.43222732 |
| 82 | Abnormal protein glycosylation (HP:0012346) | 2.43222732 |
| 83 | Abnormal glycosylation (HP:0012345) | 2.43222732 |
| 84 | Poikiloderma (HP:0001029) | 2.38994889 |
| 85 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.38979058 |
| 86 | Increased CSF lactate (HP:0002490) | 2.37873892 |
| 87 | Spontaneous hematomas (HP:0007420) | 2.35220963 |
| 88 | Exertional dyspnea (HP:0002875) | 2.34785038 |
| 89 | Oral leukoplakia (HP:0002745) | 2.34597100 |
| 90 | Gastrointestinal inflammation (HP:0004386) | 2.31925461 |
| 91 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.31471976 |
| 92 | Recurrent bronchitis (HP:0002837) | 2.30259199 |
| 93 | Hepatocellular necrosis (HP:0001404) | 2.27352683 |
| 94 | Fatigue (HP:0012378) | 2.26790478 |
| 95 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.25815821 |
| 96 | Recurrent bacterial skin infections (HP:0005406) | 2.25718692 |
| 97 | Combined immunodeficiency (HP:0005387) | 2.25111499 |
| 98 | Acute myeloid leukemia (HP:0004808) | 2.25087098 |
| 99 | Pancytopenia (HP:0001876) | 2.21668798 |
| 100 | Migraine (HP:0002076) | 2.19559179 |
| 101 | Annular pancreas (HP:0001734) | 2.19455270 |
| 102 | Microcytic anemia (HP:0001935) | 2.19108784 |
| 103 | Menorrhagia (HP:0000132) | 2.19068386 |
| 104 | Chest pain (HP:0100749) | 2.18163111 |
| 105 | Interstitial pulmonary disease (HP:0006530) | 2.18113850 |
| 106 | Increased hepatocellular lipid droplets (HP:0006565) | 2.17403961 |
| 107 | Acute encephalopathy (HP:0006846) | 2.15654622 |
| 108 | Recurrent viral infections (HP:0004429) | 2.15092334 |
| 109 | Supernumerary spleens (HP:0009799) | 2.13785075 |
| 110 | Acute hepatic failure (HP:0006554) | 2.13376948 |
| 111 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.12415640 |
| 112 | Hypoproteinemia (HP:0003075) | 2.11763149 |
| 113 | Meningitis (HP:0001287) | 2.08385323 |
| 114 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.07116730 |
| 115 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.07116730 |
| 116 | Abnormality of T cells (HP:0002843) | 2.06985485 |
| 117 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.05247251 |
| 118 | Gonadotropin excess (HP:0000837) | 2.05074200 |
| 119 | Progressive macrocephaly (HP:0004481) | 2.04936675 |
| 120 | Gastrointestinal stroma tumor (HP:0100723) | 2.04569190 |
| 121 | Inflammation of the large intestine (HP:0002037) | 2.04406396 |
| 122 | Lymphoma (HP:0002665) | 2.04179645 |
| 123 | Arterial thrombosis (HP:0004420) | 2.03952124 |
| 124 | Skin rash (HP:0000988) | 2.02663910 |
| 125 | Increased intramyocellular lipid droplets (HP:0012240) | 2.02343294 |
| 126 | Premature loss of primary teeth (HP:0006323) | 2.01053976 |
| 127 | Nasal polyposis (HP:0100582) | 1.99818580 |
| 128 | Thoracic kyphosis (HP:0002942) | 1.99467421 |
| 129 | Agammaglobulinemia (HP:0004432) | 1.98590210 |
| 130 | Broad face (HP:0000283) | 1.97941293 |
| 131 | IgG deficiency (HP:0004315) | 1.97073865 |
| 132 | Increased muscle lipid content (HP:0009058) | 1.96997809 |
| 133 | Lipid accumulation in hepatocytes (HP:0006561) | 1.95539775 |
| 134 | Gangrene (HP:0100758) | 1.94771564 |
| 135 | Bowed forearm bones (HP:0003956) | 1.94718815 |
| 136 | Bowing of the arm (HP:0006488) | 1.94718815 |
| 137 | Erythema (HP:0010783) | 1.92628596 |
| 138 | Bronchitis (HP:0012387) | 1.92568094 |
| 139 | Autoimmune thrombocytopenia (HP:0001973) | 1.92276544 |
| 140 | Depressed nasal tip (HP:0000437) | 1.91558413 |
| 141 | Recurrent fungal infections (HP:0002841) | 1.90558043 |
| 142 | B lymphocytopenia (HP:0010976) | 1.90513097 |
| 143 | Keratitis (HP:0000491) | 1.90196267 |
| 144 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88224267 |
| 145 | Chronic sinusitis (HP:0011109) | 1.87939950 |
| 146 | Abnormality of macrophages (HP:0004311) | 1.87723076 |
| 147 | Severe visual impairment (HP:0001141) | 1.87205339 |
| 148 | Abnormality of the prostate (HP:0008775) | 1.87158189 |
| 149 | Abnormality of the pleura (HP:0002103) | 1.85960074 |
| 150 | Acute lymphatic leukemia (HP:0006721) | 1.85219708 |
| 151 | Vasculitis (HP:0002633) | 1.85194439 |
| 152 | Prostate neoplasm (HP:0100787) | 1.85030749 |
| 153 | Neutropenia (HP:0001875) | 1.84567716 |
| 154 | Easy fatigability (HP:0003388) | 1.83640435 |
| 155 | Chronic diarrhea (HP:0002028) | 1.83245099 |
| 156 | Abnormal platelet volume (HP:0011876) | 1.82848719 |
| 157 | Retrobulbar optic neuritis (HP:0100654) | 1.81905875 |
| 158 | Optic neuritis (HP:0100653) | 1.81905875 |
| 159 | Bruising susceptibility (HP:0000978) | 1.81367805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MUSK | 3.98906436 |
| 2 | TGFBR1 | 3.37304222 |
| 3 | NME2 | 3.28547811 |
| 4 | TESK2 | 3.19852313 |
| 5 | STK16 | 3.07153111 |
| 6 | MST4 | 2.97983106 |
| 7 | MAP4K1 | 2.95402854 |
| 8 | EEF2K | 2.82014315 |
| 9 | KIT | 2.67736905 |
| 10 | CDK19 | 2.66379062 |
| 11 | TNIK | 2.64929618 |
| 12 | VRK2 | 2.61920807 |
| 13 | GRK6 | 2.35007591 |
| 14 | FLT3 | 2.34417630 |
| 15 | RPS6KB2 | 2.33465863 |
| 16 | TGFBR2 | 2.30297704 |
| 17 | TIE1 | 2.28147761 |
| 18 | BTK | 2.19057842 |
| 19 | JAK1 | 2.05496424 |
| 20 | ACVR1B | 2.03177098 |
| 21 | TEC | 1.97133117 |
| 22 | MAP3K12 | 1.92780490 |
| 23 | CSK | 1.83450070 |
| 24 | MATK | 1.83249279 |
| 25 | JAK3 | 1.76986492 |
| 26 | WEE1 | 1.73961413 |
| 27 | STK10 | 1.73714485 |
| 28 | ITK | 1.66701539 |
| 29 | MAP2K3 | 1.61997007 |
| 30 | PIM2 | 1.54665297 |
| 31 | TBK1 | 1.51801685 |
| 32 | SIK3 | 1.43137737 |
| 33 | ZAP70 | 1.40083750 |
| 34 | CSF1R | 1.39893208 |
| 35 | FGFR4 | 1.37780640 |
| 36 | MAP3K11 | 1.32482999 |
| 37 | DYRK3 | 1.31783799 |
| 38 | ERN1 | 1.29642793 |
| 39 | PBK | 1.28062178 |
| 40 | PRKG2 | 1.25646598 |
| 41 | BCKDK | 1.25391783 |
| 42 | MAPKAPK5 | 1.24908486 |
| 43 | KDR | 1.23795501 |
| 44 | IKBKB | 1.23472482 |
| 45 | CDK8 | 1.23382085 |
| 46 | MKNK1 | 1.21596234 |
| 47 | LRRK2 | 1.21566376 |
| 48 | MAP3K14 | 1.21061780 |
| 49 | NME1 | 1.20742607 |
| 50 | TXK | 1.20203848 |
| 51 | SYK | 1.19400233 |
| 52 | CAMKK2 | 1.17806116 |
| 53 | NUAK1 | 1.16449127 |
| 54 | IRAK4 | 1.15776895 |
| 55 | IKBKE | 1.13546338 |
| 56 | MAP2K6 | 1.12752353 |
| 57 | PASK | 1.09666431 |
| 58 | ADRBK2 | 1.09634365 |
| 59 | EPHB1 | 1.09548691 |
| 60 | MARK3 | 1.08942541 |
| 61 | CAMK1 | 1.05741566 |
| 62 | PKN2 | 1.04406455 |
| 63 | MAPKAPK3 | 1.01351656 |
| 64 | FES | 1.01100742 |
| 65 | MYLK | 0.99578525 |
| 66 | VRK1 | 0.99293551 |
| 67 | ZAK | 0.97646801 |
| 68 | NLK | 0.97185765 |
| 69 | PIM1 | 0.94793433 |
| 70 | TLK1 | 0.93639397 |
| 71 | RPS6KA4 | 0.93624437 |
| 72 | PRKCQ | 0.91391973 |
| 73 | EIF2AK3 | 0.87786297 |
| 74 | SRPK1 | 0.87238461 |
| 75 | SCYL2 | 0.87073924 |
| 76 | BLK | 0.82198420 |
| 77 | LYN | 0.82087427 |
| 78 | CDK7 | 0.81047548 |
| 79 | TYK2 | 0.80310266 |
| 80 | TAOK3 | 0.78977204 |
| 81 | CLK1 | 0.76886373 |
| 82 | TNK2 | 0.76336222 |
| 83 | HIPK2 | 0.75335922 |
| 84 | MKNK2 | 0.74543082 |
| 85 | IRAK3 | 0.73622779 |
| 86 | LCK | 0.71402906 |
| 87 | BRSK2 | 0.71235415 |
| 88 | PAK4 | 0.70873208 |
| 89 | MAP3K3 | 0.70439975 |
| 90 | RIPK4 | 0.69014053 |
| 91 | EIF2AK2 | 0.65518853 |
| 92 | BMPR2 | 0.65498101 |
| 93 | MAP3K8 | 0.64386108 |
| 94 | IRAK1 | 0.58049840 |
| 95 | GRK1 | 0.57313810 |
| 96 | MAP3K13 | 0.57109466 |
| 97 | BMPR1B | 0.56054086 |
| 98 | MAP3K7 | 0.54499675 |
| 99 | HCK | 0.49906316 |
| 100 | GRK7 | 0.49611770 |
| 101 | ILK | 0.49468755 |
| 102 | RAF1 | 0.49407814 |
| 103 | FGR | 0.48637482 |
| 104 | EIF2AK1 | 0.48233467 |
| 105 | OXSR1 | 0.46301665 |
| 106 | PAK1 | 0.45374638 |
| 107 | MAPK4 | 0.43731765 |
| 108 | ATR | 0.43572200 |
| 109 | YES1 | 0.41673114 |
| 110 | RPS6KA5 | 0.40528897 |
| 111 | FYN | 0.38906991 |
| 112 | PTK6 | 0.38799088 |
| 113 | BMX | 0.38275063 |
| 114 | ALK | 0.37370973 |
| 115 | DAPK1 | 0.37334014 |
| 116 | EPHA3 | 0.37261921 |
| 117 | TESK1 | 0.36561291 |
| 118 | RPS6KA6 | 0.36319160 |
| 119 | CDK4 | 0.36105155 |
| 120 | FGFR3 | 0.35607137 |
| 121 | FER | 0.35446820 |
| 122 | MAP3K1 | 0.35261136 |
| 123 | ADRBK1 | 0.34831797 |
| 124 | PRKCD | 0.34314289 |
| 125 | CCNB1 | 0.33498961 |
| 126 | IGF1R | 0.33138864 |
| 127 | BUB1 | 0.32746809 |
| 128 | NEK2 | 0.32578634 |
| 129 | JAK2 | 0.32168507 |
| 130 | TRPM7 | 0.32062119 |
| 131 | PRKCH | 0.32043503 |
| 132 | PIK3CG | 0.31747419 |
| 133 | PINK1 | 0.31737311 |
| 134 | TAOK2 | 0.31103544 |
| 135 | ABL1 | 0.30815262 |
| 136 | CHUK | 0.30079016 |
| 137 | PLK4 | 0.29576027 |
| 138 | DYRK2 | 0.29469731 |
| 139 | STK4 | 0.29398450 |
| 140 | EGFR | 0.28564127 |
| 141 | ARAF | 0.28241713 |
| 142 | AURKB | 0.26953519 |
| 143 | CDK9 | 0.26826941 |
| 144 | RPS6KC1 | 0.26474527 |
| 145 | RPS6KL1 | 0.26474527 |
| 146 | TSSK6 | 0.25598535 |
| 147 | CSNK2A1 | 0.25423586 |
| 148 | CSNK2A2 | 0.24608794 |
| 149 | MAPKAPK2 | 0.24451751 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 6.78991930 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.61469799 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.37584108 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.18073643 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.02129046 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.88867277 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.49363921 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.43994359 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.30797536 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.21556167 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.19849805 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.16251957 |
| 13 | RNA polymerase_Homo sapiens_hsa03020 | 2.11005413 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.09568047 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 1.97819686 |
| 16 | Spliceosome_Homo sapiens_hsa03040 | 1.97721790 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.84358809 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.78387705 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.78010626 |
| 20 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.74491812 |
| 21 | RNA degradation_Homo sapiens_hsa03018 | 1.68633273 |
| 22 | Proteasome_Homo sapiens_hsa03050 | 1.64927947 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64404426 |
| 24 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.56287747 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.56165929 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.50966718 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.45330919 |
| 28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.44482381 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44025257 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40203778 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.39538819 |
| 32 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.38090547 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.37269586 |
| 34 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.36167857 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.36126046 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.34854659 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.31974287 |
| 38 | Measles_Homo sapiens_hsa05162 | 1.31729238 |
| 39 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.28291395 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.27724841 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.21713033 |
| 42 | Purine metabolism_Homo sapiens_hsa00230 | 1.21249364 |
| 43 | Asthma_Homo sapiens_hsa05310 | 1.20274235 |
| 44 | Protein export_Homo sapiens_hsa03060 | 1.18220466 |
| 45 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.14313549 |
| 46 | Huntingtons disease_Homo sapiens_hsa05016 | 1.12015968 |
| 47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.11953433 |
| 48 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.11181383 |
| 49 | Alzheimers disease_Homo sapiens_hsa05010 | 1.10985337 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 1.06048766 |
| 51 | RNA transport_Homo sapiens_hsa03013 | 1.03960331 |
| 52 | Tuberculosis_Homo sapiens_hsa05152 | 1.03001635 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 1.01388641 |
| 54 | Galactose metabolism_Homo sapiens_hsa00052 | 1.00635280 |
| 55 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.99105445 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97464289 |
| 57 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.95564178 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.93395798 |
| 59 | Allograft rejection_Homo sapiens_hsa05330 | 0.92890940 |
| 60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91899627 |
| 61 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.91815994 |
| 62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91804312 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.89722603 |
| 64 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.88359141 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86858642 |
| 66 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.86191725 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83903823 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.81308990 |
| 69 | Basal transcription factors_Homo sapiens_hsa03022 | 0.79555406 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 0.78568219 |
| 71 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76565199 |
| 72 | Legionellosis_Homo sapiens_hsa05134 | 0.75553050 |
| 73 | Cell cycle_Homo sapiens_hsa04110 | 0.75521017 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.75122388 |
| 75 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.74860929 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.74198763 |
| 77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.73623271 |
| 78 | Hepatitis B_Homo sapiens_hsa05161 | 0.72475528 |
| 79 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72421189 |
| 80 | Malaria_Homo sapiens_hsa05144 | 0.70156259 |
| 81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68865601 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66928615 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65023322 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.63066160 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55665831 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55353758 |
| 87 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55265182 |
| 88 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53299155 |
| 89 | Phagosome_Homo sapiens_hsa04145 | 0.53169911 |
| 90 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50200755 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49982295 |
| 92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49740545 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49275208 |
| 94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48627615 |
| 95 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48463842 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.48269957 |
| 97 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.47580703 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43062429 |
| 99 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.42873332 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41457988 |
| 101 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41445829 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40982397 |
| 103 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38144251 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37770036 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.37329589 |
| 106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36679578 |
| 107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36341145 |
| 108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36076041 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35830295 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35571327 |
| 111 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35496391 |
| 112 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.33901406 |
| 113 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.30744746 |
| 114 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.28763985 |
| 115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.27874749 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27702887 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | 0.26793912 |
| 118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.26775422 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.23418558 |
| 120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23057130 |
| 121 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.23008473 |
| 122 | Phototransduction_Homo sapiens_hsa04744 | 0.21897290 |
| 123 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.20880127 |
| 124 | Peroxisome_Homo sapiens_hsa04146 | 0.18499956 |
| 125 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15498172 |
| 126 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.13692200 |
| 127 | Olfactory transduction_Homo sapiens_hsa04740 | 0.12684798 |
| 128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.11863591 |

